“…THE FOLLOWING FINDINGS were obtained: (i) approximately 30% of patients with LC are overweight (body mass index >25), with the incidence being higher in male LC patients due to NASH and alcohol; (ii) only 30% of LC patients have adequate dietary intake for both energy and protein; (iii) iron intake (mean value, 6.7 mg/day) does not differ among CLD patients; (iv) percent arm circumference, percent arm muscle circumference, and serum concentrations of free fatty acid, tumor necrosis factor (TNF)‐α and soluble TNF receptors are significantly correlated with npRQ; 27–29 (v) serum non‐transferrin‐bound iron (NTBI) determined by a newly developed high‐performance liquid chromatography system is elevated in LC patients, 30,31 although further study is necessary to clarify whether serum NTBI levels are associated with the development of HCC; (vi) plasma amino acid imbalance is closely associated with the numbers and functions of peripheral dendritic cells; 32 (vii) long‐term zinc supplementation therapy in LC patients tends to decrease HCC occurrence; (viii) LES and administration of α‐glucosidase inhibitor improve impaired glucose tolerance; 33–35 (ix) supplementation of BCAA granules and BCAA‐enriched nutrients improve liver function and energy metabolism; 36,37 and (x) supplementation of BCAA granules inhibits carcinogenesis in a mouse model of NASH, possibly via improvement of insulin resistance 38 …”